ness, but not subcutaneous thickness, was significantly and independently associated with GDM (odds ratio 34.047, 95% confidence interval 9.489-122.166). Conclusions: Sonographic thickness of maternal visceral adipose tissue at 24-28 weeks' gestation was higher in women with GDM compared to nondiabetic pregnancies, independently from other known risk factors associated with GDM.
sents the remaining 15% [6] . It has been shown that an excessive accumulation of adipose tissue into the visceral compartment is associated with an increased risk for metabolic disorders [7] [8] [9] [10] . Some studies have investigated the measurement of maternal adipose compartments by ultrasound in patients with GDM, showing that an increased thickness of visceral adipose tissue in the first trimester of pregnancy was associated with subsequent development of metabolic disorders [11] [12] [13] [14] .
The aim of this study was to examine the sonographic measurement of maternal subcutaneous and visceral adipose thickness in pregnant women with GDM and in nondiabetic patients.
Methods
In this prospective case-control study, we included women with a singleton pregnancy attending our Center for routine antenatal visits at 24-28 weeks' gestation and patients attending the diabetic clinic following the diagnosis of GDM. Cases of known prepregnancy diabetes mellitus, GDM diagnosed in the first trimester (fasting plasma glucose level ≥92 mg/dL) [15] , chronic drug therapy, previous epigastric surgery, and fetal chromosomal and/or major structural abnormalities were excluded. In all pregnancies, gestational age was calculated based on the ultrasound measurement of crown-rump length before 14 weeks' gestation [16] .
In accordance with the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations [15] , all women underwent a 75-g oral glucose tolerance test of for the diagnosis of GDM between 24 and 28 weeks' gestation. The diagnosis of GDM was made using the IADPSG criteria as follows: fasting glucose ≥92 mg/dL or glucose levels ≥180 mg/dL after 60 min and/or ≥153 mg/dL after 120 min from glucose administration. For each woman with a positive oral glucose tolerance test, two cases with a negative test were enrolled as controls.
In all cases, after informed consent, a transabdominal ultrasound (RAB 4-8 MHz probe, Voluson E8 Expert, GE Medical Systems, Milwaukee, WI, USA) examination was carried out to measure fetal biometry and assess amniotic fluid and Doppler flow velocity in the umbilical artery. Additionally, a midsagittal section of the upper maternal abdomen was obtained, ensuring that the minimum possible pressure was applied with the ultrasound transducer on the abdomen (Fig. 1a) as previously described [17] . On each image, the following landmarks were identified: skin, subcutaneous tissue, linea alba, liver, and xiphoid process. The subcutaneous adipose thickness was measured as the maximum vertical distance from the skin line to the anterior edge of the linea alba. The visceral adipose thickness was measured on the same image from the posterior edge of the linea alba to the anterior surface of the left lobe of the liver (Fig. 1b) .
The measurements were undertaken off-line, on stored ultrasound images, by an operator (F.D.) who was not aware of any clinical information, including the results from the glucose challenge test. In 90 randomly selected cases, the measurements of subcutaneous and visceral adipose thickness were carried out twice by the same operator (F.D.) and in 44 cases independently by two operators (F.D., F.C.).
Information on obstetric and neonatal outcomes were retrieved from the hospital records and entered into a computer database for analysis. Large-for-gestational-age neonates were defined based on a birthweight at or above the 90th percentile.
The study was approved by the Institutional Review Board of Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy (reference n.2955).
Statistical Analysis
The distribution of subcutaneous and visceral thickness was made Gaussian after logarithmic transformation. Multiple regression analysis was used to determine which factors, among maternal age, ethnicity, BMI, parity, and gestational age, were significantly associated with subcutaneous and visceral thicknesses in nondiabetic pregnancies. In all regression models, stepwise forward algorithms were performed to select variables at a p value cutoff of 0.05.
The subcutaneous and visceral thicknesses, expressed as multiples of the median (MoM) of the normal group, were compared between patients with GDM and nondiabetic pregnancies.
The Student t test and Pearson χ 2 test were performed for univariate comparisons of continuous and categorical variables, respectively. The Bland-Altman analysis was used to compare the measurement agreement and bias for a single examiner and between two examiners [18] . Logistic regression analysis was used to determine the variables that were significantly associated with GDM. Univariate analysis was carried out to examine the individual variables contributing to GDM by assessing their odds ratios and 95% confidence intervals. Subsequently, multivariate logistic regression analysis with backward stepwise elimination was performed to determine which of these variables provide a significant independent contribution in the logistic model.
The data were analyzed using the statistical package IBM SPSS 22.0 (IBM, New York, NY, USA) and Excel for Windows 2010 (Microsoft Corp., Redmond, WA, USA).
Results
After exclusion of 8 patients with a first-trimester plasma glucose level of ≥92 mg/dL and 4 women with known prepregnancy diabetes, measurements of subcutaneous and visceral adipose tissue were carried out in 173 cases. Of these, 5 patients were lost to follow-up, leaving a population of 56 women with a positive glucose challenge test and 112 nondiabetic pregnancies for data analysis.
The mean maternal age was 34.5 years (SD 5.1) and mean gestational age at ultrasound was 27.3 weeks (SD 1.3). Mean subcutaneous and visceral adipose thicknesses in nondiabetic women were 9.3 mm (SD 3.6) and 9.7 mm (SD 2.2), respectively. The respective values in patients with GDM were 10.7 mm (SD 4.8) and 10.1 mm (SD 3.0). Regression analysis showed a significant association of subcutaneous and visceral thicknesses with gestational age at measurement. The regression equations are reported below: log (expected) subcutaneous adipose thickness = 1.774311 -(0.031241 × gestational age); log (expected) visceral adipose thickness = 1.518001 -(0.0215341 × gestational age).
After adjustment for gestational age, the mean subcutaneous thickness MoM in patients with GDM was significantly higher compared to nondiabetic pregnancies (1.31 vs. 1.07; p = 0.011). Similarly, the mean visceral thickness MoM was higher in women with a positive oral glucose tolerance test compared to controls (1.61 vs. 1.06; p < 0.001).
The mean difference and the 95% limits of agreement between paired measurements of subcutaneous and visceral thicknesses by the same observer were 0.092 mm (-2.166 to 1.982) and 0.016 mm (-1.994 to 1.961), respectively. The values in paired measurements by two different observers were 0.328 mm (-3.218 to 3.874) and 0.237 mm (-1.970 to 2.444), respectively.
Comparisons in maternal demographic and obstetric characteristics between the two study groups are shown in Table 1 . Univariate logistic regression analysis demonstrated that maternal age, family history of diabetes mellitus, BMI, and sonographic subcutaneous and visceral adipose thicknesses were significantly associated with GDM. However, the contribution of subcutaneous thickness did not remain independently significant in the multivariate model (Table 2 ).
Discussion
The findings of this study show that sonographic thickness of maternal visceral adipose tissue at 24-28 weeks' gestation was higher in women with GDM compared to nondiabetic pregnancies, independently from other known risk factors associated with GDM.
Previous studies have assessed body fat distribution in the nonpregnant population using computed tomography and/or magnetic resonance imaging. Neeland et al. [9] examined 732 patients with obesity and found an independent association between type 2 diabetes and the visceral fat mass, but not with subcutaneous adiposity or BMI. Similarly, Bray et al. [10] examined 1,106 subjects and reported that the visceral adipose mass was independently associated with diabetes mellitus type 2, with no significant relationship between subcutaneous adipose tissue and glucose intolerance. Therefore, there is evidence that the visceral adipose tissue may be involved in the regulation of glucose metabolism and that excessive visceral adiposity is associated with increased insulin resistance.
Some studies investigated the relationship between glycemic status in pregnancy and sonographic thickness of maternal adipose tissue, mostly based on small groups of cases evaluated during the first trimester of pregnancy [11] [12] [13] [14] . Bartha et al. [11] examined 30 women at 11-14 weeks' gestation and found a significant association between sonographic measurement of visceral adipose tissue and glycemia, insulinemia, and insulin sensitivity. Martin et al. [12] reported that a visceral adipose thickness above the upper quartile of the normal range in the first trimester of pregnancy was significantly more frequent in 6 cases that subsequently developed GDM compared to 56 controls. In another recent study carried out at 4-14 weeks' gestation in 94 pregnant women, Gur et al. [13] showed that visceral adipose tissue, more than BMI, was associated with the risk of developing GDM, dyslipidemia, hypertension, and insulin resistance. However, the study population comprised only patients with obesity, who are known to be at increased risk for such disorders, and included 16 cases with a diagnosis of GDM. To the best of our knowledge, this is the first study examining the differences in the sonographic measurement of maternal adipose compartments at the time of diagnosis of GDM, which is usually made at 24-28 weeks' gestation, showing that visceral adipose thickness is higher in GDM patients compared to nondiabetic pregnancies. The main limitation of our study is the case-control design and therefore, larger screening studies should be carried out to confirm our findings.
The lack of an independent association between subcutaneous adipose thickness and GDM in our study is consistent with previous findings in nonpregnant individuals in relation to type 2 diabetes [8, 9] . In adults, most of the weight gain is determined by progressive accumulation of adipose tissue into the subcutaneous compartment, with consequent increase in the BMI. It has been previously shown that pregnant women with obesity have a significantly higher risk of developing GDM [4] and therefore, measurement of the BMI is the most practical and effective method of quantifying the subcutaneous adipose mass. Traditional risk factors for the development of GDM are increased maternal age, family history of di- abetes mellitus, and high BMI, and our data are consistent with these findings (Table 1 ). The present study also showed that the association between visceral adipose thickness and GDM remained significant when other variables were taken into account in the multiple regression model ( Table 2 ), suggesting that increased visceral adiposity may be an independent factor associated with GDM. We could not show any significant difference between the study groups in the rate of Asian ethnicity, previous pregnancy with GDM, and previous macrosomic baby, which are also considered as risk factors for GDM, and the likely explanation is that the prevalence of these conditions in our population was very low in both groups (Table 1) . Recent studies have shown that more than 70% of pregnant women that will develop GDM can be identified at 11-13 weeks' gestation, by combining information from maternal history and biophysical and biochemical markers into specific screening algorithms [19] [20] [21] . Large prospective studies can evaluate whether the inclusion of the visceral adipose thickness, measured in the first trimester of pregnancy, may provide an additional contribution in early identification of women at risk of developing GDM. First-trimester screening for GDM has the main advantage of selecting a high-risk group of women who may benefit from early dietary intervention or preventive medications, once their efficacy has been demonstrated by randomized controlled trials, with the primary objective to reduce the prevalence of GDM and its related fetomaternal complications.
